Study title: Ettinger-L-J, Sinniah-D, Siegel-S-E, Fishman-L-S, Segall-H-D, Soni-D, Bennetts-G-A, Schultz-D-H, Raphael-D. Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors. Journal of neuro-oncology, {J-Neurooncol}, 1985, vol. 3, no. 3, p. 263-9, ISSN: 0167-594X.Ettinger-L-J, Sinniah-D, Siegel-S-E, Fishman-L-S, Segall-H-D, Soni-D, Bennetts-G-A, Schultz-D-H, Raphael-D. Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors. Journal of neuro-oncology, {J-Neurooncol}, 1985, vol. 3, no. 3, p. 263-9, ISSN: 0167-594X.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Neoplasms [C04] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: PROCARBAZINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |